<?xml version="1.0" encoding="UTF-8"?>
<p>Ebola virus belongs to the Filoviridae family of enveloped viruses and contains a non-segmented negative-strand RNA genome [
 <xref rid="pntd.0005622.ref001" ref-type="bibr">1</xref>,
 <xref rid="pntd.0005622.ref002" ref-type="bibr">2</xref>]. Infection in humans can cause Ebola hemorrhagic fever, with exceptionally high case-fatality rates of more than 50% [
 <xref rid="pntd.0005622.ref003" ref-type="bibr">3</xref>,
 <xref rid="pntd.0005622.ref004" ref-type="bibr">4</xref>]. The incubation period of Ebola virus disease (EVD) is 2 to 21 days [
 <xref rid="pntd.0005622.ref005" ref-type="bibr">5</xref>]. The clinical signs and symptoms are extremely similar to those of the Marburg virus and include fever, body aches, vomiting, diarrhea, rash and, in some cases, both internal and external bleeding [
 <xref rid="pntd.0005622.ref005" ref-type="bibr">5</xref>]. Patients usually die of multiple-organ failure or hypovolemic shock. No licensed therapeutic or prophylactic treatments are currently available.
</p>
